Heart Transplant Current Events

Heart Transplant Current Events, Heart Transplant News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Heart transplant patients at risk for serious skin cancers
A new study published in the American Journal of Transplantation reveals that there is a significant risk of serious skin cancers, including cutaneous squamous cell carcinoma and melanoma, in heart transplant patients. (2011-06-30)

Using smaller hearts could increase donor pool
The donor heart pool could be expanded by including undersized hearts, according to a study presented today at the International Society of Heart and Lung Transplantation. (2004-04-24)

Racial, gender disparities observed in heart transplant recipients with COVID-19 infection
Researchers suggest focusing on disparities to help identify which patients with a heart transplant may be at higher risk for a worse course of COVID-19 infection. (2020-06-09)

New drug is safer and more effective in preventing heart tranplant rejection
Findings presented Thursday (April 22, 2004) at the International Society for Heart and Lung Transplantation show that the immunosuppressant everolimus is not only more effective but also safer than standard therapy in preventing heart transplant rejection. (2004-04-23)

First case of heart recovery with VentrAssist reported
Ventracor today reported the first case of recovery of a patient's heart allowing removal of the VentrAssist left ventricular assist device after providing support for over 12 months. (2006-10-16)

Lung cancer risk particularly high for heart and liver transplant recipients
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ (2010-05-01)

Noninvasive Test Detects Heart Rejection
Findings of a multicenter study indicate that Pacemaker Guided Monitoring has a high predictive value for determining heart rejection. The use of an implanted pacemaker can serve as an early warning for future rejection in heart recipients. The use of a pacemaker to detect heart transplant rejection is less invasive, more cost effective with less severe side effects as compared to endomyocardial biopsy which results in localized bleeding, infection and arrhythmias. (1998-04-17)

Does the new heart transplant allocation policy encourage gaming by providers?
A new national policy was created to make determining who receives a heart transplant more fair. But new data shows it changed some practice patterns, too. (2020-10-20)

Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco. (2007-04-26)

International Study Raises Hopes For Heart Transplant Patients
Preliminary six month findings of a multicenter international study indicate that the organ rejection drug, Neoral, offers significant benefits to heart transplant recipients. This two-year study compares Neoral with conventional Cyclosporine A in 380 heart transplant recipients. Patients receiving Neoral experienced significantly fewer infections and a reduced number of rejections requiring antibody therapy. (1998-04-18)

Valve disease impacts survival while awaiting heart transplant
In a study presented Thursday (April 22, 2004), Temple University researchers reported that survival to transplant rates decreased significantly when patients had abnormal or diseased aortic valves before receiving a left ventricular assist device or LVAD. (2004-04-23)

Medicare Approves UM Medical Center For Lung Transplants
The federal Health Care Financing Administration has designated the University of Maryland Medical Center as a Medicare-approved lung transplant center, which means that elderly patients who need the surgery no longer have to travel outside the mid-Atlantic region. (1998-01-13)

Heart transplant recipients can improve fitness and perform high intensity workouts
Heart transplant recipients' cardio-respiratory fitness is around 30 to 50 percent lower than age-matched healthy sedentary individuals. As a result, exercise rehabilitation should be very important to these patients, and a University of Alberta study shows they can improve their overall physical fitness. (2009-07-02)

Regadenoson is safe, effective for use in heart transplant patients
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a Henry Ford Hospital study. Researchers say the 25 patients in the study did not experience adverse side effects such as abnormally low blood pressure or slow heart beat when regadenoson was used during the stress test. (2010-03-14)

Age should not be a factor in determining heart transplantation eligibility, researchers say
Policy makers who use age as a discriminating factor in determining eligibility for heart transplant surgery may want to reconsider their rules in the light of new research at the University of Alberta. (2005-02-14)

Approval to start US BTT pivotal trial
Ventracor has received approval from the US Food & Drug Administration to begin enrollment in the US Bridge To Transplant Pivotal Trial of the VentrAssist Left Ventricular Assist Device. (2007-04-04)

ACHRI study finds CellCept® improves survival in pediatric heart transplant patients
Pediatric heart transplant recipients taking the medication CellCept® (mycophenolate mofetil) as part of their anti-rejection treatment regimen experienced significantly fewer early rejection episodes and greatly improved survival, according to a study of nearly 400 pediatric patients, beginning two weeks post-transplant. The study was led by researchers at the Arkansas Children's Research Institute (ACHRI) and results were presented today at the 25th annual meeting of the International Society for Heart and Lung Transplantation in Philadelphia. (2005-04-11)

Heart Laser Surgery: An Alternative To Transplantation
Heart laser surgery replaces transplantation in patients with severe coronary artery disease. Patients receiving Transmyocardial Revascularization (TMR) experienced survival rates of 85% which compares favorably with survival at 1 year post transplant. TMR offers an alternative to transplant patients without the side effects of immunosuppression therapy and mortality associated with waiting for a transplant. (1998-04-17)

'Molecular microscope' system safer, more effective in heart and lung transplant biopsies
A transplant biopsy system that uses gene chips to read molecules is far safer and more effective than existing approaches used for heart transplant biopsies and is showing promising results for lung transplant biopsies, new University of Alberta-led research shows. (2018-04-12)

Massachusetts General Hospital performs first-of-its-kind heart transplant in New England
Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts. (2020-01-10)

UCSF marks a milestone with 500th transplant in heart and lung program
UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung. (2008-04-24)

US sees declining use of available donor hearts for transplantation despite a growing waiting list
Increasing numbers of people in the United States are developing heart failure, which leads to death within five years in approximately half of patients. (2015-02-10)

Baylor team discovers reason for heart transplant failure
A common virus that infects the heart is a major reason for heart transplant failure in children, Baylor College of Medicine reports. The discovery shows why many children suffer heart transplant failure months and even years after surgery, including cardiac rejection and the development of transplant coronary artery disease. (2001-05-16)

Study shows one anti-rejection drug works better to prevent harmful blood clots in heart transplant patients
The anti-rejection drugs that keep people alive after a heart transplant also increase the threat of potentially fatal blood clots. But a University of Maryland Medical Center study finds that one popular anti-rejection drug poses less risk of clotting in heart transplant patients than another commonly used medicine. Results of the study are published in last month's issue of The Journal of Heart and Lung Transplantation. (2000-01-03)

Some patients are candidates for combined heart bypass, lung transplant surgeries
For patients who have been precluded from receiving a lung transplant because of their underlying coronary artery disease, Duke University Medical Center researchers have shown that they can achieve similar positive outcomes by performing revascularization procedures such as coronary bypass operations immediately prior to the transplant surgery. (2002-05-20)

Using skin to save the heart
Cell therapies for heart ailments involve transplanting over a billion heart cells to the patient's heart. Many of these cells fail to engraft, however, compromising the benefits. One reason for the poor engraftment is that normally the heart cell population is a mixture of cells with different maturation. Researchers have identified an ideal maturation stage that enhances engraftment and may reduce the number of cells required for therapy. (2016-01-08)

South Asians at twice the risk of heart attack and death after transplant: study
South Asian men and women have more than twice the risk of suffering a heart attack after a kidney transplant, according to a study led by St. Michael's nephrologist Dr. Ramesh Prasad. (2010-09-30)

Yale succeeds with a more inclusive approach to heart transplants
Doctors at Yale New Haven Hospital used a more aggressive selection process to more than quadruple the number of heart transplants performed there while maintaining positive patient outcomes, according to a new study. (2020-09-18)

University of Louisville/Jewish Hospital program helps avoid, delay heart transplant
Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are benefiting from a new recovery protocol at the University of Louisville and Jewish Hospital. (2012-03-12)

Texas Children's discharges history-making patient
The wait is over for 16-year-old Francesco (2010-02-12)

Researchers develop new way to predict heart transplant survival
Johns Hopkins researchers say they have developed a formula to predict which heart transplant patients are at greatest risk of death in the year following their surgeries, information that could help medical teams figure out who would benefit most from the small number of available organs. (2011-09-02)

New use of artificial lung device pioneered at University of Kentucky
Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial‑lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang. (2011-08-04)

White pediatric heart transplant patients more likely than non-whites to survive long term
White heart transplant patients under the age of 18 are more than twice as likely to be alive a decade after surgery as their African-American counterparts, new Johns Hopkins research suggests. (2011-11-13)

Heart, heart-lung and lung transplant recipients can have successful pregnancies
Women who have received a heart, heart-lung or lung transplant are having successful pregnancies after transplantation, according to a study by researchers at Jefferson Medical College. While such pregnancies are considered (2002-08-30)

First patient ever receives successful transplant after using 50cc Total Artificial Heart
A California woman became the first patient in the world to receive a successful heart transplant at Ronald Reagan UCLA Medical Center thanks to an experimental Total Artificial Heart designed for smaller patients. The successful transplant is giving doctors new hope that the device could provide a solution for patients with smaller chest cavities in the future. (2015-07-01)

UCLA's heart transplant program ranked among nation's best
The heart transplant program at Ronald Reagan UCLA Medical Center has again been recognized as one of highest ranking in the nation by an agency of the US Department of Health and Human Services. (2012-10-19)

The 'Break Even' Cost Of Kidney Transplants Is Shrinking
The cost of a kidney transplant has dropped so significantly that University of Maryland School of Medicine researchers say it is cheaper to have a transplant than to stay on dialysis for more than two and a half years, even among the sickest patients. (1999-05-20)

U of A researchers can predict heart transplant patient's health earlier
Michael Mengel, a pathology researcher with the Faculty of Medicine & Dentistry, has found a new way to analyze biopsies from heart transplant patients by looking at their genes. This allows him to make an early prediction whether the transplant is working. (2010-11-10)

Survival rates lower for heart transplant patients whose arteries reclose after stenting
New research by UCLA researchers and colleagues has found that heart transplant patients who develop restenosis after receiving a stent have poor long-term survival. (2012-06-18)

Cedars-Sinai heart transplantation tip sheet
Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. (2010-04-24)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.